Form 4: Tecogen Inc. Director Earl R. Lewis Reports Stock Option Grant

Director Earl R. Lewis reports acquisition of stock options in Tecogen Inc.

Summary

• On June 6, 2024, Earl R. Lewis, a director of Tecogen Inc. [TGEN], reported the acquisition of 25,000 stock options with an exercise price of $0.77.
• These options vest 25% per year, beginning June 6, 2025, and expire on June 6, 2034.
• Following the transaction, Lewis directly owns 200,000 derivative securities.

Sentiment

Score: 6

Explanation: Neutral sentiment as it's a routine disclosure of stock option grants to a company director. The vesting schedule is a positive sign for long-term alignment.

Positives

• The grant of stock options to a director aligns their interests with those of the shareholders.
• The vesting schedule encourages long-term commitment from the director.

Industry Context

This is a standard practice for incentivizing company directors and aligning their interests with shareholders.

Comparison to Industry Standards

• Stock option grants are a common form of executive compensation across various industries.
• Vesting schedules, such as the 25% annual vesting described, are typical to ensure long-term commitment.
• The specific terms of the option grant (exercise price, vesting schedule, expiration date) would need to be compared to similar companies in the energy or technology sectors to determine if they are competitive.

Stakeholder Impact

• The stock option grant aligns the director's interests with shareholders, potentially driving long-term value creation.

Key Dates